Status Update: Automated Insulin Delivery Devices
While there’s LOTS of talk about what are now referred to as Automated Insulin Delivery (AID) systems (rather than artificial pancreas systems), many people don’t fully understand how these devices will work and what they’ll actually accomplish. This blog written for the T1D Exchange, describes the evolution to AID systems, details the current and near-future devices in a related table and discusses the clinical and mental health benefits of AID systems.
Latest News on CGM and Dexcom Straight from the CEO, Kevin Sayer
A Look Inside the FDA’s Review Processes for Medical Devices
For years I’ve heard the terms “FDA-approved,” “FDA-cleared,” and “510-k application,” associated with the review of medical devices at the U.S. FDA, but I wasn’t clear on their definitions.
Bigfoot Unity Cleared and Ready to Step Out: Interview with Jeffrey Brewer, CEO, Bigfoot Biomedical
I was given the golden opportunity to interview a diabetes care and innovation guru, Jeffrey Brewer, for the T1D Exchange.